Cerba HealthCare Italia continues its journey alongside Inter Milan, to consolidate their partnership in sports medicine and athlete preparation.

The brand remains as Official Lab Partner for the 2022-23 sports season. To follow the partnership during the 2021-22 season, Cerba HealthCare Italia will continue to support Inter Milan providing regular blood and saliva tests as a contribution to evaluating the athleticism of its footballers.
 

“We are delighted to continue working in synergy with Cerba HealthCare for the second year running. It is a cause for great satisfaction for us that the largest Italian group in the field of outpatient diagnostics and laboratory analysis has decided to continue as our partner for the upcoming season as testament to all the work done in our first year together”, said Alessandro Antonello, Corporate CEO of FC Internazionale Milano. “For us, Cerba HealthCare is an invaluable partner, in terms of its contribution to ensuring the well-being of our athletes, which is critical for us.”

“The combination of medicine, technology and sport is central to the work of Cerba HealthCare and we are proud to put our experience at the service of a team at the apex of Italian and international football”, stated Stefano Massaro, CEO of Cerba HealthCare Italia.“Our latest-generation tests will provide Inter Milan’s medical and technical staff with valuable support to monitor player performance during matches and throughout the season. Data analysis will offer useful indications to maintain consistently optimal performance and to plan the workloads of the athletes, so they can recover as quickly as possible from fatigue and oxidative stress, as well as preventing muscle injuries.”

With its Sports Medicine centres, Cerba HealthCare Italia follows up over 100,000 athletes worldwide per year and boasts an extensive network of 2,000 employees, 440 sites and 25 million tests per year on 6 million patients.